keyword
https://read.qxmd.com/read/38576350/proof-of-concept-study-exploring-the-effect-of-spesolimab-in-patients-with-moderate-to-severe-hidradenitis-suppurativa-a-randomized-double-blind-placebo-controlled-clinical-trial
#21
JOURNAL ARTICLE
Afsaneh Alavi, Errol Prens, Alexa B Kimball, John W Frew, James G Krueger, Sutirtha Mukhopadhyay, Heli Gao, Usha Ranganathan, Nathalie B Ivanoff, Ana C Hernandez Daly, Christos C Zouboulis
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a considerable disease burden. Existing treatment options are limited and often suboptimal; a high unmet need exists for effective targeted therapies. OBJECTIVE: To explore the effects of spesolimab treatment in patients with HS. METHODS: This randomized, double-blind, placebo-controlled, proof-of-clinical-concept study was conducted at 25 centers across 12 countries from May 3, 2021, to April 21, 2022...
April 5, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38573788/a-bayesian-quasi-likelihood-design-for-identifying-the-minimum-effective-dose-and-maximum-utility-dose-in-dose-ranging-studies
#22
JOURNAL ARTICLE
Feng Tian, Ruitao Lin, Li Wang, Ying Yuan
Most existing dose-ranging study designs focus on assessing the dose-efficacy relationship and identifying the minimum effective dose. There is an increasing interest in optimizing the dose based on the benefit-risk tradeoff. We propose a Bayesian quasi-likelihood dose-ranging design that jointly considers safety and efficacy to simultaneously identify the minimum effective dose and the maximum utility dose to optimize the benefit-risk tradeoff. The binary toxicity endpoint is modeled using a beta-binomial model...
April 4, 2024: Statistical Methods in Medical Research
https://read.qxmd.com/read/38568725/designing-developing-and-testing-a-chatbot-for-parents-and-caregivers-of-children-and-young-people-with-rheumatological-conditions-the-impact-study-protocol-for-a-co-designed-proof-of-concept-study
#23
JOURNAL ARTICLE
Polly Livermore, Klaudia Kupiec, Lucy R Wedderburn, Andrea Knight, Ameenat L Solebo, Roz Shafran, Glenn Robert, N J Sebire, Faith Gibson
BACKGROUND: Pediatric rheumatology is a term that encompasses over 80 conditions affecting different organs and systems. Children and young people with rheumatological chronic conditions are known to have high levels of mental health problems and therefore are at risk of poor health outcomes. Clinical psychologists can help children and young people manage the daily difficulties of living with one of these conditions; however, there are insufficient pediatric psychologists in the United Kingdom...
April 3, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38565814/long-acting-exenatide-does-not-prevent-cognitive-decline-in-mild-cognitive-impairment-a-proof-of-concept-clinical-trial
#24
JOURNAL ARTICLE
A Dei Cas, M M Micheli, R Aldigeri, S Gardini, F Ferrari-Pellegrini, M Perini, G Messa, M Antonini, V Spigoni, G Cinquegrani, A Vazzana, V Moretti, P Caffarra, R C Bonadonna
PURPOSE: According to preclinical evidence, GLP-1 receptor may be an actionable target in neurodegenerative disorders, including Alzheimer's disease (AD). Previous clinical trials of GLP-1 receptor agonists were conducted in patients with early AD, yielding mixed results. The aim was to assess in a proof-of-concept study whether slow-release exenatide, a long-acting GLP-1 agonist, can benefit the cognitive performance of people with mild cognitive impairment (MCI). METHODS: Thirty-two (16 females) patients were randomized to either slow-release exenatide (n = 17; 2 mg s...
April 2, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38563763/a-measles-vectored-vaccine-candidate-expressing-prefusion-stabilized-sars-cov-2-spike-protein-brought-to-phase-i-ii-clinical-trials-candidate-selection-in-a-preclinical-murine-model
#25
JOURNAL ARTICLE
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
In the early COVID-19 pandemic with urgent need for countermeasures, we aimed at developing a replicating viral vaccine using the highly efficacious measles vaccine as vector, a promising technology with prior clinical proof of concept. Building on our successful pre-clinical development of a measles virus (MV)-based vaccine candidate against the related SARS-CoV, we evaluated several recombinant MV expressing codon-optimized SARS-CoV-2 spike glycoprotein. Candidate V591 expressing a prefusion-stabilized spike through introduction of two proline residues in HR1 hinge loop, together with deleted S1/S2 furin cleavage site and additional inactivation of the endoplasmic reticulum retrieval signal, was the most potent in eliciting neutralizing antibodies in mice...
April 2, 2024: Journal of Virology
https://read.qxmd.com/read/38561821/noninvasive-spinal-stimulation-improves-walking-in-chronic-stroke-survivors-a-proof-of-concept-case-series
#26
JOURNAL ARTICLE
Yaejin Moon, Chen Yang, Nicole C Veit, Kelly A McKenzie, Jay Kim, Shreya Aalla, Lindsey Yingling, Kristine Buchler, Jasmine Hunt, Sophia Jenz, Sung Yul Shin, Ameen Kishta, V Reggie Edgerton, Yury P Gerasimenko, Elliot J Roth, Richard L Lieber, Arun Jayaraman
BACKGROUND: After stroke, restoring safe, independent, and efficient walking is a top rehabilitation priority. However, in nearly 70% of stroke survivors asymmetrical walking patterns and reduced walking speed persist. This case series study aims to investigate the effectiveness of transcutaneous spinal cord stimulation (tSCS) in enhancing walking ability of persons with chronic stroke. METHODS: Eight participants with hemiparesis after a single, chronic stroke were enrolled...
April 1, 2024: Biomedical Engineering Online
https://read.qxmd.com/read/38547766/identification-of-adme-genes-polymorphic-variants-linked-to-trastuzumab-induced-cardiotoxicity-in-breast-cancer-patients-case-series-of-mono-institutional-experience
#27
JOURNAL ARTICLE
Nicoletta Staropoli, Francesca Scionti, Valentina Farenza, Federica Falcone, Francesco Luciano, Maria Renne, Maria Teresa Di Martino, Domenico Ciliberto, Ludovica Tedesco, Antonella Crispino, Caterina Labanca, Maria Cucè, Stefania Esposito, Giuseppe Agapito, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri, Mariamena Arbitrio
BACKGROUND: Long-term survival induced by anticancer treatments discloses emerging frailty among breast cancer (BC) survivors. Trastuzumab-induced cardiotoxicity (TIC) is reported in at least 5% of HER2+BC patients. However, TIC mechanism remains unclear and predictive genetic biomarkers are still lacking. Interaction between systemic inflammation, cytokine release and ADME genes in cancer patients might contribute to explain mechanisms underlying individual susceptibility to TIC and drug response variability...
March 27, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38547135/the-vertigo-trial-protocol-a-prospective-single-center-patient-blinded-study-to-evaluate-efficacy-and-safety-of-prolonged-daily-stimulation-with-a-multichannel-vestibulocochlear-implant-prototype-in-bilateral-vestibulopathy-patients
#28
JOURNAL ARTICLE
Bernd L Vermorken, Benjamin Volpe, Stan C J van Boxel, Joost J A Stultiens, Marc van Hoof, Rik Marcellis, Elke Loos, Alexander van Soest, Chris McCrum, Kenneth Meijer, Nils Guinand, Angélica Pérez Fornos, Vincent van Rompaey, Elke Devocht, Raymond van de Berg
BACKGROUND: A combined vestibular (VI) and cochlear implant (CI) device, also known as the vestibulocochlear implant (VCI), was previously developed to restore both vestibular and auditory function. A new refined prototype is currently being investigated. This prototype allows for concurrent multichannel vestibular and cochlear stimulation. Although recent studies showed that VCI stimulation enables compensatory eye, body and neck movements, the constraints in these acute study designs prevent them from creating more general statements over time...
2024: PloS One
https://read.qxmd.com/read/38546724/augmenting-k-means-clustering-with-qualitative-data-to-discover-the-engagement-patterns-of-older-adults-with-multimorbidity-when-using-digital-health-technologies-proof-of-concept-trial
#29
JOURNAL ARTICLE
Yiyang Sheng, Raymond Bond, Rajesh Jaiswal, John Dinsmore, Julie Doyle
BACKGROUND: Multiple chronic conditions (multimorbidity) are becoming more prevalent among aging populations. Digital health technologies have the potential to assist in the self-management of multimorbidity, improving the awareness and monitoring of health and well-being, supporting a better understanding of the disease, and encouraging behavior change. OBJECTIVE: The aim of this study was to analyze how 60 older adults (mean age 74, SD 6.4; range 65-92 years) with multimorbidity engaged with digital symptom and well-being monitoring when using a digital health platform over a period of approximately 12 months...
March 28, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38544553/effect-of-plasma-exchange-with-albumin-replacement-on-albumin-functionality-and-organ-dysfunction-in-acute-on-chronic-liver-failure
#30
JOURNAL ARTICLE
Javier Fernández, Miquel Lozano, Mireia Torres, Raquel Horrillo, Natalia Afonso, Laura Núñez, Anna Mestre, Alba Pérez, Joan Cid, Montserrat Costa, Vicente Arroyo, Antonio Páez
BACKGROUND & AIMS: Effective treatments for acute-on-chronic liver failure (ACLF) are a major unmet need. This proof-of-concept pilot study was aimed at evaluating the effects of plasma exchange (PE) with albumin 5% (PE-A5%) on albumin functional capacity and organ dysfunction in patients with ACLF. METHODS: Ten adult patients were enrolled in a single-center phase II, prospective, open-label, non-controlled study. Six PE-A5% sessions were performed in 10 days followed by a 1-month follow-up visit...
April 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38541946/proof-of-concept-of-telemedicine-assisted-abdominal-ultrasound-examinations-to-improve-the-quality-of-patient-care-in-rural-areas
#31
JOURNAL ARTICLE
Tobias Kleemann, Denise Müller, Carola Güther, Alina Duma, Awsan Mohamed, Helmut Ernst, Madlen Löbel, Robert Freund, Sven Kleemann, Sven Pannach, Rutker Stellke, Dirk Briesemann, Tina Diepelt, Ina Thomas, Viktoria Ermisch, Dimitrios Aretakis, Alexander Wree, Frank Tacke, Steffen Ortmann, Marten Schulz
(1) Background: Unclear sonographic findings without adequate specialist expertise in abdominal ultrasound (AU) may harm patients in rural areas, due to overlooked diagnoses, unnecessary additional imaging (e.g., CT scan), and/or patient transport to referral expert centers. Appropriate telemedical sonography assistance could lead to corresponding savings. (2) Methods: The study was designed as a randomized trial. Selected study centers performed AU with the best local expertise. Patients were selected and monitored according to the indication that they required AU...
March 17, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38529267/interpersonal-neural-synchrony-and-mental-disorders-unlocking-potential-pathways-for-clinical-interventions
#32
Kerstin Konrad, Christian Gerloff, Simon H Kohl, David M A Mehler, Lena Mehlem, Emily L Volbert, Maike Komorek, Alina T Henn, Maren Boecker, Eileen Weiss, Vanessa Reindl
INTRODUCTION: Interpersonal synchronization involves the alignment of behavioral, affective, physiological, and brain states during social interactions. It facilitates empathy, emotion regulation, and prosocial commitment. Mental disorders characterized by social interaction dysfunction, such as Autism Spectrum Disorder (ASD), Reactive Attachment Disorder (RAD), and Social Anxiety Disorder (SAD), often exhibit atypical synchronization with others across multiple levels. With the introduction of the "second-person" neuroscience perspective, our understanding of interpersonal neural synchronization (INS) has improved, however, so far, it has hardly impacted the development of novel therapeutic interventions...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38527849/adjunctive-pascolizumab-in-rifampicin-susceptible-pulmonary-tuberculosis-proof-of-concept-partially-randomised-double-blind-placebo-controlled-dose-escalation-trial
#33
JOURNAL ARTICLE
Nicholas I Paton, Meera Gurumurthy, Qingshu Lu, Francesca Leek, Philip Kwan, Hiromi W L Koh, James Molton, Lalaine Mortera, Sullian Naval, Zamzurina Abu Bakar, Yong-Kek Pang, Lionel Lum, Tow Keang Lim, Gail B Cross, Ganesh Lekurwale, Hyungwon Choi, Veonice Au, John Connolly, Martin Hibberd, Justin A Green
BACKGROUND: Interleukin-4 (IL-4), increased in tuberculosis infection, may impair bacterial killing. Blocking IL-4 confers benefit in animal models. We evaluated safety and efficacy of pascolizumab (humanised anti-IL-4 monoclonal antibody) as adjunctive tuberculosis treatment. METHODS: Participants with rifampicin-susceptible pulmonary tuberculosis received a single intravenous infusion of pascolizumab or placebo; and standard 6-month tuberculosis treatment. Pascolizumab dose increased in successive cohorts: [1] non-randomised 0...
March 25, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38526612/a-muscarinic-receptor-antagonist-reverses-multiple-indices-of-diabetic-peripheral-neuropathy-preclinical-and-clinical-studies-using-oxybutynin
#34
RANDOMIZED CONTROLLED TRIAL
Carolina M Casselini, Henri K Parson, Katie E Frizzi, Alex Marquez, Darrell R Smith, Lucie Guernsey, Rakesh Nemmani, Alireza Tayarani, Corinne G Jolivalt, Jessica Weaver, Paul Fernyhough, Aaron I Vinik, Nigel A Calcutt
Preclinical studies indicate that diverse muscarinic receptor antagonists, acting via the M1 sub-type, promote neuritogenesis from sensory neurons in vitro and prevent and/or reverse both structural and functional indices of neuropathy in rodent models of diabetes. We sought to translate this as a potential therapeutic approach against structural and functional indices of diabetic neuropathy using oxybutynin, a muscarinic antagonist approved for clinical use against overactive bladder. Studies were performed using sensory neurons maintained in vitro, rodent models of type 1 or type 2 diabetes and human subjects with type 2 diabetes and confirmed neuropathy...
March 25, 2024: Acta Neuropathologica
https://read.qxmd.com/read/38526401/how-the-food-and-drug-administration-drug-approval-process-relates-to-the-potential-approval-of-intravenous-racemic-ketamine-for-treatment-resistant-major-depression
#35
JOURNAL ARTICLE
Sheldon H Preskorn
This column focuses on the status of intravenous racemic ketamine for the treatment of patients suffering from a form of major depressive disorder that does not respond to trials of currently available biogenic amine antidepressants. To provide context, the column reviews the 3 pivotal elements of the usual Food and Drug Administration (FDA) drug approval process: (1) the unmet medical need (ie, the indication) for which the drug is being developed, (2) the efficacy of the drug for that condition, and (3) the safety/tolerability of the drug...
March 1, 2024: Journal of Psychiatric Practice
https://read.qxmd.com/read/38516816/utility-of-a-short-form-phonemic-fluency-task
#36
JOURNAL ARTICLE
Jack R Kaufman, Hudaisa Fatima, Laura H Lacritz, C Munro Cullum
OBJECTIVE: to establish a proof-of-concept and ascertain the reliability of an abbreviated 30-second (30s) phonemic fluency measure as a cognitive screening tool in older adults. METHODS: in all, 201 English-speaking individuals with normal cognition (NC; n = 119) or cognitive impairment (CI; mild CI or dementia; n = 82) were administered a standard 60s phonemic fluency task (FAS/CFL) with discrete 30s intervals denoted. RESULTS: for all letters, 30s trial scores significantly predicted 60s scores for the same letter, R2 = ...
March 21, 2024: Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists
https://read.qxmd.com/read/38513684/safety-and-immunogenicity-of-the-co-administered-na-apr-1-and-na-gst-1-hookworm-vaccines-in-school-aged-children-in-gabon-a-randomised-controlled-observer-blind-phase-1-dose-escalation-trial
#37
JOURNAL ARTICLE
Jeannot F Zinsou, David J Diemert, Jean Claude Dejon-Agobé, Bayodé R Adégbité, Yabo Josiane Honkpehedji, Kafui G Vodonou, Rodrigue Bikangui, Jean Ronald Edoa, Marguerite Massinga Loembe, Guangzhao Li, Maria Yazdanbakhsh, Maria Elena Bottazzi, Remko van Leeuwen, Peter G Kremsner, Peter J Hotez, Jeffrey M Bethony, Martin P Grobusch, Ayola A Adegnika
BACKGROUND: A human hookworm vaccine is being developed to protect children against iron deficiency and anaemia associated with chronic infection with hookworms. Necator americanus aspartic protease-1 (Na-APR-1) and N americanus glutathione S-transferase-1 (Na-GST-1) are components of the blood digestion pathway critical to hookworm survival in the host. Recombinant Na-GST-1 and catalytically inactive Na-APR-1 (Na-APR-1[M74]) adsorbed to Alhydrogel were safe and immunogenic when delivered separately or co-administered to adults in phase 1 trials in non-endemic and endemic areas...
March 18, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38513424/amygdala-real-time-fmri-neurofeedback-upregulation-in-treatment-resistant-depression-proof-of-concept-and-dose-determination
#38
JOURNAL ARTICLE
Laurie Compère, Greg J Siegle, Sair Lazzaro, Emily Riley, Marlene Strege, Gia Canovali, Scott Barb, Theodore Huppert, Kymberly Young
Previous work has shown that adults suffering from major depressive disorder (MDD) can increase their amygdala reactivity while recalling positive memories via real-time neurofeedback (rt-fMRI-nf) training, which is associated with reduction in depressive symptoms. This study investigated if this intervention could also be considered for patients suffering from MDD who do not respond to standard psychological and pharmacological interventions, i.e., treatment resistant (TR-MDD). 15 participants received 5 neurofeedback sessions...
March 15, 2024: Behaviour Research and Therapy
https://read.qxmd.com/read/38512117/a-signal-finding-study-of-abemaciclib-in-heavily-pretreated-patients-with-metastatic-castration-resistant-prostate-cancer-results-from-cyclone-1
#39
JOURNAL ARTICLE
Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa, Jose Angel Arranz Arija, Emeline Colomba, Gwenaelle Gravis, Loic Mourey, Stephane Oudard, Aude Fléchon, Macarena Gonzalez, Pablo M Maroto, Michael T Schweizer, Enrique Gallardo, Erica Johnston, Arjun Balar, Nadine Haddad, Adams K Appiah, Karim Nacerddine, Josep M Piulats
BACKGROUND: Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors radically changed the treatment paradigm for breast cancer. Similar to estrogen receptor in breast cancer, androgen receptor signaling activates cyclin D-CDK4/6, driving proliferation and resistance to hormonal manipulation in prostate cancer. This study was designed to detect signals of clinical activity for abemaciclib in treatment-refractory metastatic castration-resistant prostate cancer (mCRPC). METHODS: Eligible patients had progressive mCRPC, measurable disease, and previously received ≥1 novel hormonal agent(s) and 2 lines of taxane chemotherapy...
March 21, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38509415/detecting-aortic-valve-stenosis-based-on-the-non-invasive-blood-pressure%C3%A2-waveform-a-proof-of-concept-study
#40
JOURNAL ARTICLE
Eline Kho, Jimmy Schenk, Alexander P J Vlaar, Marije M Vis, Marije Wijnberge, Lotte B Stam, Martijn van Mourik, Harald T Jorstad, Henning Hermanns, Berend E Westerhof, Denise P Veelo, Bjorn J P van der Ster
The incidence of aortic valve stenosis (AoS) increases with age, and once diagnosed, symptomatic severe AoS has a yearly mortality rate of 25%. AoS is diagnosed with transthoracic echocardiography (TTE), however, this gold standard is time consuming and operator and acoustic window dependent. As AoS affects the arterial blood pressure waveform, AoS-specific waveform features might serve as a diagnostic tool. Aim of the present study was to develop a novel, non-invasive, AoS detection model based on blood pressures waveforms...
March 20, 2024: GeroScience
keyword
keyword
85925
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.